Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
Open Access
- 29 July 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (35) , 57021-57035
Abstract
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresKeywords
This publication has 37 references indexed in Scilit:
- The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsLeukemia, 2014
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Epigenetic alterations in hematopoietic malignanciesInternational Journal of Hematology, 2012
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel SequencingCell, 2012
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3ABlood, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceLeukemia, 2011
- Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2009
- RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformationLeukemia, 2009
- Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasiaBlood, 2006